Agência FAPESP – Developed by Biologix , a startup headquartered in São Paulo, Brazil, a sleep apnea home diagnostic and monitoring system based on the Internet of Things can be used for the remote monitoring of individuals with suspected COVID-19 or mild symptoms of the disease.
“In hospitals, the system can be used to monitor noncritical COVID-19 patients and leave intensive care unit beds free for critical patients,” Almeida said.
The technology can also be used by hospitals, health management organizations and insurers to monitor not only patients with suspected COVID-19 or mild symptoms of the disease but also older people and other members of the groups most at risk of developing a severe form of the disease.
The team advises immediate hospitalization if, in addition to the data showing a fall in oxygen saturation and heart rate, the patient or carer reports fever, a cough, fatigue and difficulty breathing, which are typical symptoms of infection by SARS-CoV-2.
The physical part of the system is a cordless portable sensor, which, when placed on the patient’s index finger, captures oxygen saturation and heart rate data.